Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 229 (6%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3283 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-FLUVOXAMINE | 100MG | TABLET | Resolved | 2021-11-01 | 2021-11-29 | 148587 |
| APO-FLUVOXAMINE | 100MG | TABLET | Resolved | 2022-02-11 | 2022-02-22 | 154756 |
| APO-FLUVOXAMINE | 50MG | TABLET | Resolved | 2022-02-11 | 2022-02-22 | 154759 |
| APO-FOSINOPRIL | 20MG | TABLET | Resolved | 2017-03-10 | 2017-04-10 | 324 |
| APO-FOSINOPRIL | 10MG | TABLET | Resolved | 2017-03-11 | 2017-04-10 | 658 |
| APO-FOSINOPRIL | 20MG | TABLET | Resolved | 2021-07-16 | 2021-08-03 | 142677 |
| APO-FOSINOPRIL | 20MG | TABLET | Resolved | 2023-10-06 | 2024-02-16 | 206582 |
| APO-FOSINOPRIL | 10MG | TABLET | Resolved | 2024-02-09 | 2024-02-16 | 219168 |
| APO-FOSINOPRIL | 20MG | TABLET | Resolved | 2024-03-27 | 2024-04-26 | 223558 |
| APO-FOSINOPRIL | 10MG | TABLET | Resolved | 2024-04-26 | 2024-05-03 | 226339 |
| APO-FROVATRIPTAN | 2.5MG | TABLET | Resolved | 2017-09-06 | 2017-10-10 | 21082 |
| APO-FROVATRIPTAN | 2.5MG | TABLET | Resolved | 2019-04-01 | 2020-06-29 | 80264 |
| APO-FROVATRIPTAN | 2.5MG | TABLET | Resolved | 2021-07-16 | 2021-09-01 | 142680 |
| APO-FROVATRIPTAN | 2.5MG | TABLET | Resolved | 2022-06-30 | 2022-09-02 | 163722 |
| APO-FROVATRIPTAN | 2.5MG | TABLET | Resolved | 2023-07-13 | 2023-07-21 | 198508 |
| APO-FUROSEMIDE | 20MG | TABLET | Resolved | 2024-03-22 | 2024-04-19 | 223067 |
| APO-GABAPENTIN | 800MG | TABLET | Resolved | 2017-09-26 | 2017-10-31 | 23558 |
| APO-GABAPENTIN | 600MG | TABLET | Resolved | 2017-11-28 | 2018-03-22 | 31001 |
| APO-GABAPENTIN | 800MG | TABLET | Resolved | 2017-11-28 | 2018-03-22 | 31004 |
| APO-GABAPENTIN | 600MG | TABLET | Resolved | 2019-01-09 | 2019-01-12 | 71662 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
| APO-HYDROMORPHONE CR | 30MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110971 |
| APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |
| APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |
| APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |